WallStreetZenWallStreetZen

NASDAQ: BGLC
Bionexus Gene Lab Corp Stock Ownership - Who owns Bionexus Gene Lab?

Insider buying vs selling

Have Bionexus Gene Lab Corp insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BGLC insiders and whales buy or sell their stock.

BGLC Shareholders

What type of owners hold Bionexus Gene Lab Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Tai Tan Liong70.75%12,500,460$7.43MInsider
Wei Li Leong27.16%4,797,709$2.85MInsider
Citadel Advisors LLC0.19%33,591$19.95kInstitution
Virtu Financial LLC0.15%26,149$15.53kInstitution
Geode Capital Management LLC0.13%23,681$14.07kInstitution
Two Sigma Securities LLC0.08%14,919$8.86kInstitution
Tower Research Capital LLC Trc0.03%5,831$3.46kInstitution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

BGLC vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BGLC0.59%97.91%
PRPO0.61%99.39%Net BuyingNet Buying
CHEK1.07%0.00%
XWEL1.65%98.35%Net Buying
CNTG9.75%0.00%

Bionexus Gene Lab Stock Ownership FAQ

Who owns Bionexus Gene Lab?

Bionexus Gene Lab (NASDAQ: BGLC) is owned by 0.59% institutional shareholders, 97.91% Bionexus Gene Lab insiders, and 1.50% retail investors. Tai Tan Liong is the largest individual Bionexus Gene Lab shareholder, owning 12.50M shares representing 70.75% of the company. Tai Tan Liong's Bionexus Gene Lab shares are currently valued at $7.43M.

If you're new to stock investing, here's how to buy Bionexus Gene Lab stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.